Considerable knowledge about how we function has come through the use of the unicellular microbe yeast. Yeasts are eukaryotes like us and the similarity between us and yeasts is readily visible at the molecular level. This places yeast as an important tool for industries involved in health research, including pharmaceutical and nutraceutical discovery.
* studies on autophagy to Yoshinori Ohsumi (2016).
These discoveries are important for humans since we can extrapolate from yeast studies, where we have knowledge from mutants and genetic engineering, to make statements like 'in this particular aspect this is how we function'. So human proteins can be identified by the similarity to a yeast protein whose function is characterised and in many cases there can be complementation with a human protein in a yeast deletion mutant.
There is higher complexity in humans but it is often due to our multicellular nature. More cell types mean proteins may have multiple isoforms for specialisation and novel functions. Conversely, there is a well-recognised genome duplication of Saccharomyces cerevisiae that adds complexity to this model yeast. However, our knowledge of that duplication and the capability to remove sequences at will means that this model eukaryote can be engineered to produce the human proteins in the context that we want to study, enabling us to test ideas and develop new therapies.
For example, this engineering might include the functional replacement of the duplicated RAS1/2, HMG1/2, or TOR1/2 genes, with the equivalent human genes for cancer, cholesterol pathway, or protein turnover studies in S. cerevisiae. 
Yeast to study chronic diseases
Chronic diseases, including cancer, heart disease, fibromyalgia,
Parkinson's disease and Alzheimer's disease (AD), are of interest to us because they are common and their incidence increases with age, important factors that drive the search for cures. There are huge economic benefits that can result from advances in treatment of such chronic diseases. These diseases are a huge burden to our society, but to industry they represent valuable opportunities for revenue, since people may require treatments for the remainder of their life.
As a model organism, yeast can provide information in many ways.
A few selected examples are listed in Table 1 and some examples are described in a little more detail below. In addition, several recent reviews also discuss the use of yeast as model [17] [18] [19] .
Yeast can contribute to cancer research providing information on cell growth and cell death as well as the mechanisms of resistance to cancer drugs such as methotrexate where yeast can become resistant through over-production of dihydrofolate reductase In Focus
This can explain muscle fatigue and why most athletes discontinue their prescribed statins.
In the case of AD, the effects of the AD-associated amyloid beta (Ab)
protein can be studied in genetically engineered yeast that produce 
Age-related diseases and nutraceutical testing
Aging is responsible for many chronic diseases: as we age we see increases in a spectrum of diseases. It is impossible to stop aging but if we could slow it we could reduce the burden of many diseases.
The cause of aging is debatable but it is clear that old cells exhibit reduced lifespan, accumulation of aberrant proteins, reduced telomeres and mitochondrial dysfunction. The budding yeast
Saccharomyces cerevisiae also exhibits these behaviours and can be used as a model to look for compounds that restore health to old cells. Alzheimer's disease Autophagy of Ab can be studied: compounds promoting Ab removal can be screened.
5-7
Parkinson's disease alpha synuclein is toxic. 8 Prion disease Yeast have prions (affecting just yeast) that can be 'cured'.
9
Cancer Cell cycle can be studied in Schizosaccharomyes pombe, a yeast that divides by fission.
Resistance to cancer drugs like methotrexate can be studied in yeast. 10, 11 Malaria Plasmodium drug targets and resistance (e.g. DHPS and DHFR) can be modelled in yeast.
12
HIV HIV-1 Vpr causes a growth arrest in yeast and humans: inhibitors of that effect can be screened in yeast.
13
Biogenic amines Dopamine and phenylethylamine toxicity in yeast can be overcome with antioxidants.
14,15
Aging Yeast exhibit aging symptoms including telomere shortening, mtDNA deletions and reduced autophagy. Telomere shortening can also be studied in yeast.
The power of numbers in microbes can provide answers to the problems 
Conclusions
Similarities in yeast and human cells mean that yeast can be surrogates to model disease processes and treatments. Yeast offer many opportunities for physiological, genetic and molecular manipulation, so in many instances they offer mimicry of processes where we are seeking pharmaceutical or nutraceutical interventions.
